Serveur d'exploration sur la maladie de Parkinson - Corpus (Accueil)

Index « ISSN » - entrée « J Neurol »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J Neuro-Oncol < J Neurol < J Neurol Neurosurg Psychiatry  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
Ident.Authors (with country if any)Title
000009 (1993) Peter JennerMaladie de Parkinson: mécanismes physiopathologiques et effets du piribédil
000087 (1982) Kurt JellingerAdjuvant treatment of parkinson's disease with dopamine agonists: Open trial with bromocriptine and CU 32-085
000425 (1993) P. Rondot ; M. ZieglerActivité et acceptabilité du piribédil dans la maladie de Parkinson: étude multicentrique
000433 (1990) K. KosakaDiffuse lewy body disease in Japan
000762 (1992) C. Corbe ; F. Arnaud ; Y. Brault ; C. Janiak-BolzingerEffect of a dopaminergic agonist, piribedil (Trivastal 50 mg LP), on visual and spatial integration in elderly subjects
000812 (1993) B. Dubois ; B. Pillon ; Y. AgidDétérioration des voies dopaminergiques et altérations des fonctions cognitives et motrices
000826 (1990) G. GoldenbergPerformance of concurrent non-motor tasks in parkinson's disease
000890 (1997) B. Dubois ; Bernard PillonCognitive deficits in Parkinson’s disease
000900 (1994) Mario Zappia ; Rita Montesanti ; Rosanna Colao ; Aldo QuattroneUsefulness of movement time in the assessment of Parkinson's disease
000A14 (1989) M. Brenner ; A. Haass ; P. Jacobi ; K. SchimrigkAmantadine sulphate in treating Parkinson's disease: Clinical effects, psychometric tests and serum concentrations
000A21 (1984) P. Jeanty ; M. Van Den Kerchove ; A. Lowenthal ; H. De BruynePergolide therapy in parkinson's disease
000A45 (1987) Kurt Jellinger ; Harald BliesathAdjuvant treatment of Parkinson's disease with budipine: a double-blind trial versus placebo
000B21 (1993) C. Corbe ; F. Arnaud ; Y. Brault ; C. Janiak-BolzingerEffet d'un agoniste dopaminergique, le piribédil (Trivastal 50 mg LP) sur l'intégration visuelle spatiale du sujet âgé
000D76 (1982) E. Schneider ; -A. FischerLong-term experience with bromocriptine in advanced parkinsonism
000E68 (1985) E. Schneider ; H. Baas ; P.-A. Fischer ; G. JappThree-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism
000F92 (1983) M. YoshimuraCortical changes in the parkinsonian brain: a contribution to the delineation of “diffuse Lewy body disease”
001222 (1989) M. Ludin ; P. LudinIs Parkinson's disease of early onset a separate disease entity?
001252 (1992) Peter JennerParkinson's disease: pathological mechanisms and actions of piribedil
001270 (1987) G. Ransmayr ; B. Schmidhuber-Eiler ; E. Karamat ; S. Engler-Plörer ; W. Poewe ; K. LeidlmairVisuoperception and visuospatial and visuorotational performance in Parkinson's disease
001453 (1991) S. CompstonBook review — James Parkinson: his life and times by A. D. Morris
001768 (1992) P. Rondot ; M. ZieglerActivity and acceptability of piribedil in Parkinson's disease: a multicentre study
001872 (1991) G. Bellomo ; L. Santambrogio ; M. Fiacconi ; M. Scarponi ; G. CiuffettiPlasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated parkinson's disease
001966 (1991) Giuseppe Meco ; Luca Pratesi ; Vincenzo BonifatiCardiovascular reflexes and autonomic dysfunction in parkinson's disease
001D25 (1992) L. Angelini ; N. Nardocci ; V. Rumi ; C. Zorzi ; L. Strada ; M. SavoiardoHallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life
002549 (1995) Parkinson's disease
002585 (1996) F. Tison ; K. Wenning ; A. Volonte ; R. Poewe ; P. Henry ; P. QuinnPain in multiple system atrophy
002764 (1994) Letizia Mazzini ; Daniela Testa ; Carla Balzarini ; Gabriele MoraAn open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis
002983 (1986) J. Ulrich ; A. Probst ; M. WüestThe brain diseases causing senile dementia
002C47 (1989) F. Boomsma ; D. Meerwaldt ; J. Man In'T Veld ; A. Hovestadt ; H. SchalekampTreatment of idiopathic parkinsonism with l -dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of l -dopa, dopa decarboxylase, catecholamines and 3-O-methyl-dopa
003016 (1987) S. Kosti ; M. Djuri I ; N. Ovi Kovi Terni ; L. Bumbaširevi ; M. Nikoli ; B. MršuljaDepression and parkinson's disease: possible role of serotonergic mechanisms

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i -k "J Neurol" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i  \
                -Sk "J Neurol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    J Neurol
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024